Kyrgyzstan vs Qatar: Access to anti-retroviral drugs, male
Kyrgyzstan
48.0%
in 2024
Qatar
47.0%
in 2024
Kyrgyzstan rank
120th
Qatar rank
122nd
Access to anti-retroviral drugs, male over time
- Kyrgyzstan
- Qatar
How they compare
Kyrgyzstan currently reports 48.0% against 47.0% in Qatar, a difference of 1.0%.
The two have swapped places 3 times across 17 shared years of data; in 2000 it was Qatar ahead.
Kyrgyzstan ranks 120th and Qatar ranks 122nd of 141 countries.
Across the 3 decades both report, Kyrgyzstan averaged higher in 1 and Qatar in 2.
Head to head by decade
| Decade | Kyrgyzstan | Qatar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.1% | 0.0% | 1.1% | Kyrgyzstan |
| 2010s | 28.0% | 38.4% | 10.4% | Qatar |
| 2020s | 42.8% | 45.2% | 2.4% | Qatar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Kyrgyzstan or Qatar?
- Kyrgyzstan, at 48.0% against 47.0% in Qatar as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Kyrgyzstan and Qatar?
- 1.0%, with Kyrgyzstan ahead.
- How many years of comparable data are there for Kyrgyzstan and Qatar?
- 17 years are reported by both, from 2000 to 2024.
- How do Kyrgyzstan and Qatar rank globally for access to anti-retroviral drugs, male?
- Kyrgyzstan ranks 120th and Qatar ranks 122nd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.